Medicines

  1. Nuedexta (dextromethorphan HBr and quinidine sulfate)
    Nuedexta (dextromethorphan HBr and quinidine sulfate)
    by Avanir Pharmaceuticals
    for Pseudobulbar Affect (PBA)
    €1,536.00
  2. Relumina (relugolix)
    Relumina (relugolix)
    by Takeda Pharma A/S
    for
    €1,256.40
  3. Orilissa (elagolix)
    Orilissa (elagolix)
    by AbbVie Ltd
    for
    €1,050.06
  4. Takhzyro (lanadelumab)
    Takhzyro (lanadelumab)
    by Shire Pharmaceuticals
    for Hereditary angioedema (HAE)
    €17,768.40
  5. Cablivi (caplacizumab)
    Cablivi (caplacizumab)
    by Ablynx NV
    for
    €6,792.00
  6. Lorbrena/Lorviqua (lorlatinib)
    Lorbrena/Lorviqua (lorlatinib)
    by Pfizer Limited
    for Lung Cancer
    €8,382.72
  7. Kalydeco (ivacaftor)
    Kalydeco (ivacaftor)
    by Vertex Pharmaceuticals (Europe) Ltd
    for Cystic Fibrosis
    €12,807.00
  8. Symkevi / Symdeko (tezacaftor/ivacaftor)
    Symkevi / Symdeko (tezacaftor/ivacaftor)
    by Vertex Pharmaceuticals (Europe) Ltd
    for Cystic Fibrosis
    €7,795.80
  9. Vitrakvi (larotrectinib)
    Vitrakvi (larotrectinib)
    by Bayer
    for Solid Tumor
    €15,204.00
View as Grid List

Items 1-9 of 70

Page
per page
Set Descending Direction